Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$24.25 0.29 (1.21%)
2/9/2010 4:00 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating:
****

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating BMY

Add Stock to Watchlist

What the Community Thinks

Total Members

1422 Outperforms
96 Underperforms
 

All-Stars

451 Outperforms
13 Underperforms
 

Wall Street

18 Outperforms
1 Underperforms
 

Members bullish on BMY are also bullish on:

Members bearish on BMY are also bearish on:

Ticker Tags

Healthcare (711), Income (1401), Big Pharma (10), Pharmaceuticals (149), S&P 500 (499), Blue Chip (106), Defensive (1457), Dividend (191), New York (31), Large Cap (413), Six Sigma® (31), Growth (1902)
Suggest a tag

Bristol-Myers Squibb Co. At A Glance

Current Price: $24.25
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $23.96
Daily Range: $23.90 - $24.41
52-Week Range: $17.23 - $26.62
Volume: 9,733,359
Market Cap: $48.04B
P/E Ratio: 12.95
Compare Our Special Broker Offers!

Stock Trends

BMY VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Bristol-Myers Squibb Co. (BMY)

Avatar symie5 (38.06) Submitted: 2/04/10 12:06 PM

Stable, solid dividend...

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3

Bristol-Myers Squibb Co. (BMY)

Avatar manchesteruk (< 20) Submitted: 10/05/06 3:30 AM

only potential M&A make this stock attractive

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 213 :   1 2 3 4 5 Next » Jump to page:

Recs

1

 (BMY)

Avatar symie5 (38.06) Submitted: 2/04/10 12:06 PM : Outperform Start Price: $24.07 BMY Score: 0.98

Stable, solid dividend...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (BMY)

Avatar thievaryx (94.49) Submitted: 1/14/10 10:40 AM : Outperform Start Price: $25.00 BMY Score: 3.53

Dividend Aristocrat.

Product patents are expiring, which is why this one is available on the cheap.

Company is amassing a war chest (cash) and has an interesting product pipeline.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (BMY)

Avatar timknowsnothing (57.61) Submitted: 1/08/10 10:13 PM : Outperform Start Price: $24.94 BMY Score: 4.06

cheap with cash

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (BMY)

Avatar Larchmont (84.62) Submitted: 1/08/10 9:26 AM : Outperform Start Price: $25.30 BMY Score: 1.71

Magic Formula Pick

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (BMY)

Avatar DaveOfDukeIPO (72.86) Submitted: 12/31/09 1:28 PM : Outperform Start Price: $25.54 BMY Score: -1.15

paid out a dividend of $0.32

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 213 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 19 of 19  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackWellsFargo 80.02 10/09/09 Outperform NS $21.99+10.26%+0.54%+9.71
TrackJimCramer < 20 05/08/09 Outperform 3W $19.57+23.88%+16.52%+7.36
TrackBerkowitz 83.78 05/27/08 Outperform 1Y $19.65+23.38%-19.31%+42.69 Toggle the visibility of 60-Second Pitch and replies
TrackBrandes < 20 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackBillNygren 94.66 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 90.73 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 93.31 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackRichPzena 38.72 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 97.70 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.91 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 97.67 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackHAndW 80.22 09/30/07 Outperform NS $25.20-3.77%-26.38%+22.61 Toggle the visibility of 60-Second Pitch and replies
TrackBearStearns 84.85 06/25/07 Outperform NS $27.72-12.51%-24.87%+12.36
TrackCitigroup 85.92 06/13/07 Outperform NS $25.33-4.25%-24.68%+20.44
TrackDeutscheSec 89.68 04/30/07 Outperform NS $25.57-5.15%-24.25%+19.10
TrackHSBC 86.09 04/27/07 Underperform NS $25.27-4.05%-23.97%-19.92
TrackUBS 87.99 03/01/07 Outperform NS $22.52+7.66%-18.33%+25.99
TrackLehmanBros 85.06 01/12/07 Outperform NS $22.63+7.17%-19.90%+27.07

Results 1 - 19 of 19  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 921ms